SC
HAE icon

Skylands Capital’s Haemonetics HAE Stock Holding History

Skylands Capital’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.71M Buy
65,825
+29,350
+80% +$1.91M 0.49% 60
2025
Q4 		$2.92M Sell
36,475
-44,894
-55% -$3.02M 0.4% 71
2025
Q3 		$3.97M Buy
81,369
+53,819
+195% +$3.33M 0.55% 54
2025
Q2 		$2.06M Sell
27,550
-28,225
-51% -$1.87M 0.3% 75
2025
Q1 		$3.54M Buy
55,775
+28,600
+105% +$1.95M 0.51% 57
2024
Q4 		$2.12M Buy
27,175
+3,875
+17% +$311K 0.3% 75
2024
Q3 		$1.87M Buy
+23,300
New +$1.88M 0.25% 80

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Skylands Capital's HAE Position: Q1 2026 in Review

Skylands Capital increased its Haemonetics (HAE) stake by 80% in Q1 2026, buying an estimated $1.91M and bringing the position to 65,825 shares worth $3.71M. The position accounts for 0.49% of the portfolio, ranked #60.

Skylands Capital first reported a position in HAE in Q3 2024 and has held it in 7 quarters since. The position peaked at $3.97M in Q3 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Skylands Capital held 65,825 shares of Haemonetics worth $3.71M as of Q1 2026.
  • Skylands Capital bought 29,350 Haemonetics shares in Q1 2026, an estimated $1.91M.
  • Haemonetics made up 0.49% of Skylands Capital's portfolio in Q1 2026, its #60 holding.
  • Skylands Capital first reported a position in Haemonetics in Q3 2024 and has held it in 7 quarters since.
  • Skylands Capital's Haemonetics position peaked at $3.97M in Q3 2025.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Skylands Capital's 13F filing for Q1 2026, filed 22 Apr 2026.